.
BioEnterprise

Abeona Therapeutics Licenses Next Generation AAV Gene Therapy Vector Platform

Abeona Therapeutics announces the license of a next generation gene therapy AAV capsid portfolio capable of widespread central nervous system gene transfer.

Read More  >